Omeros (OMER) Interest Coverage Ratio (2010 - 2026)
Omeros (OMER) posted Interest Coverage Ratio of 2.96 for Q1 2026, up 30.6% sequentially from 4.26 in Q4 2025, and up 13.63% YoY from 2.6 in Q1 2025.
Powered by 
Analysis
Omeros (OMER) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Omeros has reported Interest Coverage Ratio for 17 years, with the latest figure at 2.96 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 13.63% year-over-year to 2.96 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.39 (up 22.64% YoY) and the FY2025 annual result came in at 0.67, up 77.51% from the prior year.
- Interest Coverage Ratio improved to 2.96 in Q1 2026 per OMER's latest filing, from 4.26 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 3.81 in Q4 2022 and troughed at 32.89 in Q4 2024.
- A 5-year average of 5.98 and a median of 4.74 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio soared 257.53% in 2022, then slumped 1718.48% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 3.81 in 2022, then sank by 147.49% to 1.81 in 2023, then plunged by 1718.48% to 32.89 in 2024, then surged by 87.05% to 4.26 in 2025, then soared by 30.6% to 2.96 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.96, 4.26, and 1.22 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | -2.96 |
| Dec 31, 2025 | -3.33 |
| Sep 30, 2025 | 1.98 |
| Jun 30, 2025 | -2,156.93 |
| Mar 31, 2025 | -9.57 |
| Dec 31, 2024 | -10.50 |
| Sep 30, 2024 | -8.74 |
| Jun 30, 2024 | -6.42 |
| Mar 31, 2024 | -4.74 |
| Dec 31, 2023 | -5.63 |
| Sep 30, 2023 | -6.08 |
| Jun 30, 2023 | -5.16 |
| Mar 31, 2023 | -4.50 |
| Dec 31, 2022 | -5.08 |
| Sep 30, 2022 | -10.29 |
| Jun 30, 2022 | -7.60 |
| Mar 31, 2022 | -7.09 |
| Dec 31, 2021 | -8.66 |
| Sep 30, 2021 | -8.11 |